Prophylactic pancreatic stent placement and post-ERCP pancreatitis: A systematic review and meta-analysis

Endoscopy

Volumn 42, Issue 10, 2010, Pages 842-852

  Mazaki, T ^a   Masuda, H ^a   Takayama, T ^a  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHOLANGITIS; CHOLECYSTITIS; CLINICAL TRIAL; DISEASE SEVERITY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; HIGH RISK PATIENT; HUMAN; INCIDENCE; META ANALYSIS; OCCLUSION; OUTCOME ASSESSMENT; PANCREAS NECROSIS; PANCREATITIS; PATIENT SELECTION; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; PSEUDOCYST; RETROPERITONEAL DISEASE; RISK ASSESSMENT; RISK REDUCTION; STENT; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

ACUTE DISEASE; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; HUMANS; PANCREATITIS; POSTOPERATIVE COMPLICATIONS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STENTS;

EID: 77957293953     PISSN: 0013726X     EISSN: 14388812     Source Type: Journal    
DOI: 10.1055/s-0030-1255781     Document Type: Article

References (58)

1. Cotton P B., Garrow D A., Gallagher J et al. Risk factors for complications after ERCP: a multivariate analysis of 11,497 procedures over 12 years. Gastrointest Endosc 2009 70 80-88
2. Loperfido S, Angelini G, Benedetti G et al. Major early complications from diagnostic and therapeutic ERCP: a prospective multicenter study. Gastrointest Endosc 1998 48 1-10
3. Masci E, Toti G, Mariani A et al. Complications of diagnostic and therapeutic ERCP: a prospective multicenter study. Am J Gastroenterol 2001 96 417-423
4. Mehta S N., Pavone E, Barkun J S. et al. Predictors of post-ERCP complications in patients with suspected choledocholithiasis. Endoscopy 1998 30 457-463
5. Vandervoort J, Soetikno R M., Tham T C. et al. Risk factors for complications after performance of ERCP. Gastrointest Endosc 2002 56 652-656
6. Fogel E L., Eversman D, Jamidar P et al. Sphincter of Oddi dysfunction: pancreaticobiliary sphincterotomy with pancreatic stent placement has a lower rate of pancreatitis than biliary sphincterotomy alone. Endoscopy 2002 34 280-285
7. Pezzilli R, Romboli E, Campana D et al. Mechanisms involved in the onset of post-ERCP pancreatitis. JOP 2002 3 162-168
8. Freeman M L., Guda N M. Prevention of post-ERCP pancreatitis: a comprehensive review. Gastrointest Endosc 2004 59 845-864
9. Bai Y, Gao J, Zhang W et al. Meta-analysis: allopurinol in the prevention of postendoscopic retrograde cholangiopancreatography pancreatitis. Aliment Pharmacol Ther 2008 28 557-564
10. Zheng M, Bai J, Yuan B et al. Meta-analysis of prophylactic corticosteroid use in post-ERCP pancreatitis. BMC Gastroenterol 2008 8 6
11. Andriulli A, Leandro G, Federici T et al. Prophylactic administration of somatostatin or gabexate does not prevent pancreatitis after ERCP: an updated meta-analysis. Gastrointest Endosc 2007 65 624-632
12. Choi C W., Kang D H., Kim G H. et al. Nafamostat mesylate in the prevention of post-ERCP pancreatitis and risk factors for post-ERCP pancreatitis. Gastrointest Endosc 2009 69 e11-18
13. Zhang Y, Chen Q B., Gao Z Y. et al. Meta-analysis: octreotide prevents post-ERCP pancreatitis, but only at sufficient doses. Aliment Pharmacol Ther 2009 29 1155-1164
14. Rudin D, Kiss A, Wetz R V. et al. Somatostatin and gabexate for post-endoscopic retrograde cholangiopancreatography pancreatitis prevention: meta-analysis of randomized placebo-controlled studies. J Gastroenterol Hepatol 2007 22 977-983
15. Elmunzer B J., Waljee A K., Elta G H. et al. A meta-analysis of rectal NSAIDs in the prevention of post-ERCP pancreatitis. Gut 2008 57 1262-1267
16. Fazel A, Quadri A, Catalano M F. et al. Does a pancreatic duct stent prevent post-ERCP pancreatitis? A prospective randomized study. Gastrointest Endosc 2003 57 291-294
17. Harewood G C., Pochron N L., Gostout C J. Prospective, randomized, controlled study of prophylactic pancreatic stent placement for endoscopic snare excision of the duodenal ampulla. Gastrointest Endosc 2005 62 367-370
18. Patel R, Tarnasky P R., Hennessy W S. et al. Does stenting after pancreatic sphincterotomy reduce post-ERCP pancreatitis in patients with prior biliary sphincterotomy? Preliminary results of a prospective randomized study [abstract]. Gastrointest Endosc 1999 49 AB80
19. Sherman S, Blaut U, Watkins J L. et al. Does prophylactic administration of corticosteroid reduce the risk and severity of post-ERCP pancreatitis: a randomized, prospective, multicenter study [abstract]. Gastrointest Endosc 1996 43 413
20. Smithline A, Silverman W, Rogers D et al. Effect of prophylactic main pancreatic duct stenting on the incidence of biliary endoscopic sphincterotomy-induced pancreatitis in high-risk patients. Gastrointest Endosc 1993 39 652-657
21. Sofuni A, Maguchi H, Itoi T et al. Prophylaxis of post-endoscopic retrograde cholangiopancreatography pancreatitis by an endoscopic pancreatic spontaneous dislodgement stent. Clin Gastroenterol Hepatol 2007 5 1339-1346
22. Tarnasky P R., Palesch Y Y., Cunningham J T. et al. Pancreatic stenting prevents pancreatitis after biliary sphincterotomy in patients with sphincter of Oddi dysfunction. Gastroenterology 1998 115 1518-1524
23. Tsuchiya T, Itoi T, Sofuni A et al. Temporary pancreatic stent to prevent post endoscopic retrograde cholangiopancreatography pancreatitis: a preliminary, single-center, randomized controlled study. J Hepatobiliary Pancreat Surg 2007 14 302-307
24. Andriulli A, Forlano R, Napolitano G et al. Pancreatic duct stents in the prophylaxis of pancreatic damage after endoscopic retrograde cholangiopancreatography: a systematic analysis of benefits and associated risks. Digestion 2007 75 156-163
25. Masci E, Mariani A, Curioni S et al. Risk factors for pancreatitis following endoscopic retrograde cholangiopancreatography: a meta-analysis. Endoscopy 2003 35 830-834
26. Singh P, Das A, Isenberg G et al. Does prophylactic pancreatic stent placement reduce the risk of post-ERCP acute pancreatitis? A meta-analysis of controlled studies. Gastrointest Endosc 2004 60 544-550
27. Cotton P B., Lehman G, Vennes J et al. Endoscopic sphincterotomy complications and their management: an attempt at consensus. Gastrointest Endosc 1991 37 383-393
28. Mazaki T, Ebisawa K. Enteral versus parenteral nutrition after gastrointestinal surgery: a systematic review and meta-analysis of randomized controlled studies in the English literature. J Gastrointest Surg 2008 12 739-755
29. Egger M, Davey S mith G, Altman D G, eds. Systematic reviews in health care: meta-analysis in context. 2nd edn. London BMJ Books 2001
30. Sutton A J. Methods for meta-analysis in medical research. West Sussex John Wiley & Sons Ltd 2002
31. DerSimonian R, Laird N. Meta-analysis in clinical studies. Controlled Clin Trials 1986 7 177-188
32. Higgins J P., Thompson S G., Deeks J J. et al. Measuring inconsistency in meta-analyses. BMJ 2003 327 557-560
33. Ioannidis J P., Trikalinos T A. The appropriateness of asymmetry tests for publication bias in meta-analyses: a large survey. CMAJ 2007 176 1091-1096
34. Cremer M, Deviere J, Delhaye M et al. Stenting in severe chronic pancreatitis: results of medium-term follow-up in seventy-six patients. Endoscopy 1991 23 171-176
35. Rossos P G., Kortan P, Haber G B. Complications associated with pancreatic duct stenting. Gastrointest Endosc 1992 38 252
36. Johanson J F., Schmalz M J., Geenen J E. Simple modification of a pancreatic duct stent to prevent proximal migration. Gastrointest Endosc 1993 39 62-64
37. Cohen S A., Kasmin F E., Siegel J H. Alterations of pancreatic stents. Gastrointest Endosc 1994 40 256-257
38. Ashby K, Lo S K. The role of pancreatic stenting in obstructive ductal disorders other than pancreas divisum. Gastrointest Endosc 1995 42 306-311
39. Esber E, Sherman S, Earle D et al. Complications of minor papilla endoscopic pancreatic sphincterotomy. A review of 236 patients. Gastrointest Endosc 1996 43 405
40. Soltani S, Lo S K. How safe is endoscopic pancreatic sphincterotomy?. Gastrointest Endosc 1996 43 413
41. Aizawa T, Ueno N. Stent placement in the pancreatic duct prevents pancreatitis after endoscopic sphincter dilation for removal of bile duct stones. Gastrointest Endosc 2001 54 209-213
42. Fogel E L., Eversman D, Jamidar P et al. Sphincter of Oddi dysfunction: pancreaticobiliary sphincterotomy with pancreatic stent placement has a lower rate of pancreatitis than biliary sphincterotomy alone. Endoscopy 2002 34 280-285
43. Catalano M F., Linder J D., Chak A et al. Endoscopic management of adenoma of the major duodenal papilla. Gastrointest Endosc 2004 59 225-232
44. Freeman M L., Overby C, Qi D. Pancreatic stent insertion: consequences of failure and results of a modified technique to maximize success. Gastrointest Endosc 2004 59 8-14
45. Rashdan A, Fogel E L., McHenry L et al. Improved stent characteristics for prophylaxis of post-ERCP pancreatitis. Clin Gastroenterol Hepatol 2004 2 322-329
46. Ito K, Fujita N, Noda Y et al. Efficacy and safety of prophylactic pancreatic duct stent (Pit-stent) placement in patients at high-risk of post-ERCP pancreatitis. Gut 2005 54 Suppl VII A149-0
47. Fejes R, Kurucsai G, Szekely A et al. Feasibility and safety of emergency ERCP and small-caliber pancreatic stenting as a bridging procedure in patients with acute biliary pancreatitis but difficult sphincterotomy. Surg Endosc 2010 24 1878-1885
48. Chahal P, Tarnasky P R., Petersen B T. et al. Short 5Fr vs long 3Fr pancreatic stents in patients at risk for post-endoscopic retrograde cholangiopancreatography pancreatitis. Clin Gastroenterol Hepatol 2009 7 834-839
49. Das A, Singh P, Sivak M V. et al. Pancreatic-stent placement for prevention of post-ERCP pancreatitis: a cost-effectiveness analysis. Gastrointest Endosc 2007 65 960-968
50. Freeman M L. Pancreatic stents for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis. Clin Gastroenterol Hepatol 2007 5 1354-1365
51. Cennamo V, Fuccio L, Zagari R M. et al. Can a wire-guided cannulation technique increase bile duct cannulation rate and prevent post-ERCP pancreatitis? A meta-analysis of randomized controlled studies. Am J Gastroenterol 2009 104 2343-2350
52. Cheung J, Tsoi K K., Quan W L. et al. Guidewire versus conventional contrast cannulation of the common bile duct for the prevention of post-ERCP pancreatitis: a systematic review and meta-analysis. Gastrointest Endosc 2009 70 1211-1219
53. Shao L M., Chen Q Y., Chen M Y. et al. Can wire-guided cannulation reduce the risk of post-endoscopic retrograde cholangiopancreatography pancreatitis? A meta-analysis of randomized controlled trials. J Gastroenterol Hepatol 2009 24 1710-1715
54. Moher D, Pham B, Jones A et al. Does quality of reports of randomised studies affect estimates of intervention efficacy reported in meta-analyses? Lancet 1998 352 609-613
55. Jni P, Witschi A, Bloch R et al. The hazards of scoring the quality of clinical studies for meta-analysis. JAMA 1999 282 1054-1060
56. Schulz K F., Chalmers I, Hayes R J. et al. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled studies. JAMA 1995 273 408-412
57. Bakmen Y G., Safdar K, Freeman M L. Significant clinical implication of prophylactic pancreatic stent placement in previously normal pancreatic ducts. Endoscopy 2009 41 1095-1098
58. Price L H., Brandabur J J., Kozarek R A. et al. Good stents gone bad: endoscopic treatment of proximally migrated pancreatic duct stents. Gastrointest Endosc 2009 70 174-179